Another study showed that miR-29a, which targets the ATG9A and TFEB mRNAs, is down-regulated in Pancreatic Ductal Adenocarcinoma (PDAC) leading to increased ATG9A levels, autophagy flux and resistance to gemcitabine, as well as increased cancer cell migration. Here, ATG9A is linked to cancer.